ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy

Recently, we found that temozolomide (TMZ) can upregulate the expression of the multidrug-resistance protein ABCC3 in NK cells from both glioma-bearing mice and glioblastoma patients treated with dendritic cell immunotherapy combined with TMZ, allowing NK cells to escape apoptosis and favoring their...

Descripción completa

Detalles Bibliográficos
Autores principales: Pellegatta, Serena, Di Ianni, Natalia, Pessina, Sara, Paterra, Rosina, Anghileri, Elena, Eoli, Marica, Finocchiaro, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928625/
https://www.ncbi.nlm.nih.gov/pubmed/31771235
http://dx.doi.org/10.3390/ijms20235886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6928625/
https://www.ncbi.nlm.nih.gov/pubmed/31771235
http://dx.doi.org/10.3390/ijms20235886

Ejemplares similares